Clinical Trials Update: Aug. 10, 2004
Leukemia Osteoarthritis Alzheimer's Disease
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for the treatment of chronic myelogenous leukemia (CML). Volunteers at least 18 who have Philadelphia chromosome positive CML in first chronic phase with complete hematologic response and who do not have any other serious illness may be eligible. Research site located in Pittsburgh, Penn.
A pain management study for people with clinically diagnosed osteoarthritis (OA). Volunteers between 40-75 who have been clinically diagnosed with OA in the hip or knee may be eligible. Research sites located in Phoenix, Ariz.
A research study of an investigational formulation of a marketed medication for Alzheimer's disease. Volunteers 60 or older who do not have any other serious health problems and who are able to follow simple instructions for memory and attention tests may be eligible. Research site located in Flemington, NJ.
Copyright 2004 CenterWatch. All rights reserved.